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Introduction
In recent years, a large number of studies defined the characteristics of the pre-diabetic [1] . The significance of this finding was confirmed using liver-specific insulin receptor (IR) knockout mice that displayed severe insulin resistance and glucose intolerance in the face of elevated insulin levels to compensate for increased demand [2] . Moreover, insulin resistance of the liver is sufficient to cause dyslipidaemia and an increased risk for atherosclerosis [3] . The contribution of insulin signalling in the brain to maintain normoglycaemia and weight stability is supported by studies in human beings, where insulin activated cerebrocortical activity in lean subjects, but not in obese, indicating cerebral insulin resistance [4] . These studies in human beings therefore confirmed the relevance of the results obtained in neuron-specific IR knockout mice where female mice showed increased food intake, and both male and female developed diet-sensitive obesity that was accompanied by elevated body fat and plasma leptin levels, insulin resistance and hypertriglyceridaemia [5] . Thus, IR signalling in the central nervous system plays a critical role in the regulation of glucose and lipid disposal. [6, 7] . Thus, an almost complete loss of IRs in skeletal muscle was associated with alterations in lipid metabolism and fat accumulation, but was not sufficient to cause dramatic alterations in glucose metabolism whereas disruption of the glucose transporter GLUT-4 exerted marked glucose intolerance [8] .
It became clear from a large number of human and animal studies that insulin action is greatly impaired in skeletal muscle of prediabetic and overweight subjects, and it was therefore suggested that skeletal muscle plays an important role in the beginning of the disease. Surprisingly, a knockout approach using muscle-specific IR knockout mice did not provide strong evidence for a key role of primary insulin resistance in skeletal muscle in the development of a diabetic phenotype
Together [7, 9] .
We therefore addressed this issue in an alternative transgenic approach using a common modulator downstream of the insulin and IGF-1 receptor, protein kinase C (PKC) [10] . PKC isoforms are activated by elevated glucose, insulin and fatty acid concentrations; and studies using skeletal muscle of insulin resistant human beings revealed that divergent PKC isoforms are chronically up-regulated and phosphorylated in this state [11, 12] .
Among the multitude of PKC isoforms, PKC-␤2 was shown to be highly expressed in obese and diabetic mouse models [13, 14] , and several studies demonstrated that PKC-␤2 is able to disrupt the signal at the level of the IR itself as well as at the level of IR substrate (Irs) proteins through serine phosphorylation [15, 16] . We and others recently demonstrated in an in vitro approach that serine 318 in Irs1 is a specific phosphorylation site for PKC-␤2 [17] , and is related to insulin resistance in vitro and in vivo [13, 17, 18, 19] . In addition, serine 307 in Irs1 is phosphorylated by the JNK and PI 3-kinase/mTor signalling pathways [20] , and in vivo, enhanced levels of serine 307 phosphorylation were found in skeletal muscle biopsies of obese, insulin-resistant non-diabetic subjects, and accompanied by a decrease in Irs1 tyrosine phosphorylation as well as reduced insulin-dependent activation of Akt [11] .
To 
Materials and methods

Plasmid and animals
To generate a constitutively active PKC-␤2, the cDNA was mutated to contain Glu at position 25 instead of Ala. This cDNA was cloned into pMDAF2, which contains a 1.5-kb fragment of the MLC1 promoter and 0.9-kb fragment of the MLC1/3, muscle-specific enhancer [21] [22] [23] . The MLC/PKC-␤2 chimeric gene was excised from the plasmid, purified, and microinjected into fertilized eggs. The general procedures for microinjection of the chimeric gene were as described [24] .
Two [17] , and anti-phosphoserine307 Irs1 antibody (Upstate) was performed using ECL. 
Determination of 2-deoxyglucose uptake in skeletal muscle
Real-time RT-PCR
Fatty acid oxidation in skeletal muscle
Glycogen content in skeletal muscle
Glycogen levels were determined by a modification of the procedure described by Chan and Exton [29] . (Fig. 1D) , and consequently led to a diminished phosphorylation of Akt (Fig. 1E) (Fig. 1F, upper panels) . Identical results were obtained for serine 307 in Irs1 (Fig. 1F,  middle (Fig. 1F, lower panels) .
Metabolic effects of PKC-␤ 2 overexpression in skeletal muscle
To define the impact of insulin resistance in skeletal muscle on whole-body metabolism, metabolic markers in PKC-␤2 transgenic mice and their wild-type littermate controls were determined.
Male mice of the transgenic line 2 tended to be insulin resistant beginning at 12 weeks of age as determined by an intraperitoneal insulin tolerance test (Fig. 2A) . This was accompanied by a 34% reduction in 2-deoxyglucose uptake into skeletal muscle (Fig. 2B) . By contrast, 2-deoxyglucose uptake was not statistically different in the low expressing transgenic (Fig. 2B) . (Fig. 2C) (Fig. 3A) , and transgenic mice tend to display lower mitochondrial mass as determined by citrate synthase activity (wt: 0.025 Ϯ 0.004 mol/ml/min. versus tg: 0.015 Ϯ 0.003 mol/ml/min., P ϭ 0.08, n ϭ 4).
Fig. 1 Protein kinase C (PKC)-␤2 overexpression and insulin signalling in skeletal muscle of MLC-PKC-␤2 transgenic mice. (A) Total cellular RNA was obtained from non-transgenic (wt) and transgenic (tg) mice (line #2 and #25) and analysed by Northern blot (NB, top panel). PKC-␤2 protein levels and phosphorylated PKC-␤2 detected by specific immunoblotting of total protein from muscle extracts of 12-week-old male mice (transgenic line #2 and #25) (WB, middle and bottom panel). Equal loading was verified by blotting p-85. (B) Western blot analysis of PKC-␤2 expression on distinct tissues of wild-type (wt) and transgenic (tg) mice of the high expressing line 2. (C) Western blot analysis of IR tyrosine phosphorylation and expression in muscle lysates of PKC-␤2 and wild-type mice. Animals were stimulated intravenously for 5 min. with insulin (ϩ) or saline (-) as a control. Quantification for wt and the transgenic line 2 is given on the right, *P Ͻ 0.05. (D) PI 3-kinase activity and p-85 expression in skeletal muscle lysates of PKC-␤2 transgenic and wild-type animals. (E) Phosphorylation of Akt on serine 473 and Akt expression in mouse skeletal muscle lysates of PKC-␤2 transgenic and wild-type animals. Two transgenic lines (#2 and #25) were used. Each lane was loaded with muscle protein lysate from one animal and is representative of three independent experiments. (F) Mice were stimulated intravenously with insulin (ϩ) or saline (Ϫ) as a control, and Irs1 immunoprecipitates from skeletal muscle lysates were immunoblotted with serine 318 (upper panel), serine 307 (middle panel), antiphosphotyrosine (PY) and Irs1 (lower panels) antibodies in PKC-
As a result of PKC-␤2 overexpression, transgenic animals of the high expressing line displayed slightly increased fasting glucose concentrations (52 Ϯ 5 mg/dl versus 43 Ϯ 2 mg/dl) in the presence of elevated plasma insulin levels (3.7 Ϯ 0.6 ng/ml versus 2.2 Ϯ 0.4 ng/dl) to compensate for peripheral insulin resistance; but overall glucose homeostasis determined by fasting blood glucose concentrations or intraperitoneal glucose tolerance test was not significantly different in 12-week-old mice
insulin resistant PKC-␤2 transgenic animals displayed diminished expression of the nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR)-␦ and PPAR-␥ coactivator-1␤ (PGC-1␤) in skeletal muscle that are associated with alterations in genes involved in fatty © 2008 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 Insulin tolerance, glucose uptake and glucose tolerance test in PKC-␤2 transgenic and wild-type mice. (A) Insulin tolerance test in 12-week-old PKC-␤2 transgenic (black squares) and wild-type mice (white squares) after intraperitoneal injection of 1 unit/kg body weight of human regular insulin. Means Ϯ S.E.M., n ϭ 4. *P Ͻ 0.05. (B) 2-DOG uptake into skeletal muscle following intraperitoneal glucose injection in wild-type and PKC-␤2 transgenic mice. Means Ϯ S.E.M., n ϭ 6. *P Ͻ 0.05. (C) Glucose tolerance test in 12-week-old PKC-␤2 transgenic (black squares) and wild-type mice (white squares) after intraperitoneal injection of glucose. Means Ϯ S.E.M., n ϭ 4. (D) Glucose tolerance test in 6-month-old PKC-␤2 transgenic (black squares
Fat distribution and impaired insulin action and brain tissues
Since metabolic alterations related to impaired oxidative capacity are not restricted to skeletal muscle itself, we went on to define the acquired defects in individual tissues that are secondary to this phenotype. Thereby, Oil Red staining in liver tissue displayed that the metabolic phenotype in PKC-␤2 transgenic mice was accompanied by fat accumulation in the liver (Fig. 3B) [39] , and this is also true for our insulin resistant mouse model. Therefore, an increase in IMCL requires sufficient fat oxidative capacity to lower lipid metabolites [40] . This hypothesis is further supported by data showing a strong negative correlation between IMCL and insulin sensitivity in untrained subjects [41] , and levels of IMCL are elevated in first-degree relatives of patients that are insulin resistant [42] . Thus [46] . Even more, SREBP1c mRNA expression in skeletal muscle of PKC-␤2 transgenic mice was up-regulated as in morbid obese subjects [47] where massive lipid malabsorption after bariatric surgery resulted in a significant reduction in SREBP-1c mRNA expression in skeletal muscle, suggesting that this transcription factor might be involved in the accumulation of triglycerides in muscle cells of obese [48] .
In addition, besides alterations in lipid deposition in skeletal muscle, patients with type 2 diabetes exhibit severe abnormalities in the disposal of liver triglycerides termed hepatic steatosis and elevated hepatocellular lipid levels mainly account for hepatic insulin resistance [1] . In contrast to previous animal models that were 
